Demographics and baseline disease characteristics, and prognosis in different subgroups
| . | N = 27 . | 1-Year OS, % . | 1-Year PFS, % . |
|---|---|---|---|
| Total | 61.1 | 57.2 | |
| Sex | |||
| Male | 13 | 63.5 | 74.0 |
| Female | 14 | 64.3 (P = .85) | 54.0 (P = .56) |
| EMD | |||
| With EMD | 11 | 42.4 | 49.9 |
| Without EMD | 16 | 65.6 (P = .23) | 61.9 (P = .38) |
| Type of myeloma | |||
| MM | 22 | 63.5 | 55.9 |
| Plasma cell leukemia | 4 | 50.0 (P = .28) | 75 (P = .36) |
| Anaplastic plasmacytoma | 1 | ||
| Transplant history | |||
| No | 13 | 69.9 | 76.9 |
| Yes | 14 | 44.9 (P = .62) | 40.4% (P = .13) |
| High-risk karyotype | |||
| With | 11 | 62.3 | 65.5 |
| Without | 16 | 62.2 (P = .20) | 46.4 (P = .74) |
| . | N = 27 . | 1-Year OS, % . | 1-Year PFS, % . |
|---|---|---|---|
| Total | 61.1 | 57.2 | |
| Sex | |||
| Male | 13 | 63.5 | 74.0 |
| Female | 14 | 64.3 (P = .85) | 54.0 (P = .56) |
| EMD | |||
| With EMD | 11 | 42.4 | 49.9 |
| Without EMD | 16 | 65.6 (P = .23) | 61.9 (P = .38) |
| Type of myeloma | |||
| MM | 22 | 63.5 | 55.9 |
| Plasma cell leukemia | 4 | 50.0 (P = .28) | 75 (P = .36) |
| Anaplastic plasmacytoma | 1 | ||
| Transplant history | |||
| No | 13 | 69.9 | 76.9 |
| Yes | 14 | 44.9 (P = .62) | 40.4% (P = .13) |
| High-risk karyotype | |||
| With | 11 | 62.3 | 65.5 |
| Without | 16 | 62.2 (P = .20) | 46.4 (P = .74) |